10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2014 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 10, 2015) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Net revenues | $ 139,367 | 126,761 | 123,120 |
| Cost of revenues | 114,000 | 102,978 | 100,632 |
| Gross profit | 25,367 | 23,783 | 22,488 |
| Operating expenses | 16,568 | 15,746 | 15,278 |
| Operating profit | 8,799 | 8,037 | 7,210 |
| Interest expense, net | 600 | 509 | 557 |
| Loss on early extinguishment of debt | 521 | 0 | 348 |
| Income before income tax provision | 7,678 | 7,528 | 6,305 |
| Income tax provision | 3,033 | 2,928 | 2,436 |
| Income from continuing operations | 4,645 | 4,600 | 3,869 |
| Loss from discontinued operations, net of tax | (1) | (8) | (7) |
| Net income | 4,644 | 4,592 | 3,862 |
| Net loss attributable to noncontrolling interest | 0 | 0 | 2 |
| Net income attributable to CVS Health | 4,644 | 4,592 | 3,864 |
| Basic earnings per share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 3.98 | 3.78 | 3.05 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | 0.00 | (0.01) | (0.01) |
| Net income attributable to CVS Caremark (in dollars per share) | 3.98 | 3.77 | 3.04 |
| Weighted average common shares outstanding (in shares) | 1,161 | 1,217 | 1,271 |
| Diluted earnings per share: | |||
| Income from continuing operations attributable to CVS Caremark (in dollars per share) | 3.96 | 3.75 | 3.02 |
| Loss from discontinued operations attributable to CVS Caremark (in dollars per share) | 0.00 | (0.01) | (0.01) |
| Net income attributable to CVS Caremark (in dollars per share) | 3.96 | 3.74 | 3.02 |
| Weighted average common shares outstanding (in shares) | 1,169 | 1,226 | 1,280 |
| Dividends declared per common share | 1.10 | 0.90 | 0.65 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2014 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 10, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Net income | $ 4,644 | 4,592 | 3,862 |
| Other comprehensive income (loss): | |||
| Foreign currency translation adjustments, net of tax | (35) | (30) | 0 |
| Net cash flow hedges, net of tax | 4 | 3 | 3 |
| Pension and other postretirement benefits, net of tax | (37) | 59 | (12) |
| Net other comprehensive income (loss) | (68) | 32 | (9) |
| Comprehensive income | 4,576 | 4,624 | 3,855 |
| Comprehensive loss attributable to noncontrolling interest | 0 | 0 | 2 |
| Comprehensive income attributable to CVS Health | 4,576 | 4,624 | 3,853 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2014 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 10, 2015) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 132,406 | 114,993 | 113,205 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (105,362) | (91,178) | (90,032) |
| Cash paid to other suppliers and employees | (15,344) | (14,295) | (13,643) |
| Interest received | 15 | 8 | 4 |
| Interest paid | (647) | (534) | (581) |
| Income taxes paid | (2,931) | (3,211) | (2,282) |
| Net cash provided by operating activities | 8,137 | 5,783 | 6,671 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (2,136) | (1,984) | (2,030) |
| Proceeds from sale-leaseback transactions | 515 | 600 | 529 |
| Proceeds from sale of property and equipment and other assets | 11 | 54 | 23 |
| Acquisitions (net of cash acquired) and other investments | (2,439) | (415) | (378) |
| Purchase of available-for-sale investments | (157) | (226) | 0 |
| Maturity of available-for-sale investments | 161 | 136 | 0 |
| Proceeds from sale of subsidiary | 0 | 0 | 7 |
| Net cash used in investing activities | (4,045) | (1,835) | (1,849) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | 685 | (690) | (60) |
| Proceeds from issuance of long-term debt | 1,483 | 3,964 | 1,239 |
| Repayments of long-term debt | (3,100) | 0 | (1,718) |
| Purchase of noncontrolling interest in subsidiary | 0 | 0 | (26) |
| Dividends paid | (1,288) | (1,097) | (829) |
| Proceeds from exercise of stock options | 421 | 500 | 836 |
| Excess tax benefits from stock-based compensation | 106 | 62 | 28 |
| Repurchase of common stock | (4,001) | (3,976) | (4,330) |
| Net cash used in financing activities | (5,694) | (1,237) | (4,860) |
| Effect of exchange rate changes on cash and cash equivalents | (6) | 3 | 0 |
| Net increase (decrease) in cash and cash equivalents | (1,608) | 2,714 | (38) |
| Cash and cash equivalents at the beginning of the year | 4,089 | 1,375 | |
| Cash and cash equivalents at the end of the year | 2,481 | 4,089 | 1,375 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 4,644 | 4,592 | 3,862 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,931 | 1,870 | 1,753 |
| Stock-based compensation | 165 | 141 | 132 |
| Loss on early extinguishment of debt | 521 | 0 | 348 |
| Deferred income taxes and other noncash items | (58) | (86) | (111) |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (737) | (2,210) | (387) |
| Inventories | (770) | 12 | (853) |
| Other current assets | (383) | 105 | 3 |
| Other assets | 9 | (135) | (99) |
| Accounts payable and claims and discounts payable | 1,742 | 1,024 | 1,147 |
| Accrued expenses | 1,060 | 471 | 766 |
| Increase (Decrease) in Other Operating Liabilities | 13 | (1) | 110 |
| Net cash provided by operating activities | 8,137 | 5,783 | 6,671 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
CVS HEALTH CORP | ||
Ticker: CVS Fiscal Year: 2014 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2014 10-K (Filed: Feb 10, 2015) | ||
| (In Millions, except shares in actual) | ||
| As of | As of | |
| Dec 31, 2014 | Dec 31, 2013 | |
| Assets: | ||
| Cash and cash equivalents | $ 2,481 | 4,089 |
| Short-term investments | 34 | 88 |
| Accounts receivable, net | 9,687 | 8,729 |
| Inventories | 11,930 | 11,045 |
| Deferred income taxes | 985 | 902 |
| Other current assets | 866 | 472 |
| Total current assets | 25,983 | 25,325 |
| Property and equipment, net | 8,843 | 8,615 |
| Goodwill | 28,142 | 26,542 |
| Intangible assets, net | 9,774 | 9,529 |
| Other assets | 1,510 | 1,515 |
| Total assets | 74,252 | 71,526 |
| Liabilities: | ||
| Accounts payable | 6,547 | 5,548 |
| Claims and discounts payable | 5,404 | 4,548 |
| Accrued expenses | 5,816 | 4,768 |
| Short-term debt | 685 | 0 |
| Current portion of long-term debt | 575 | 561 |
| Total current liabilities | 19,027 | 15,425 |
| Long-term debt | 11,695 | 12,841 |
| Deferred income taxes | 4,036 | 3,901 |
| Other long-term liabilities | 1,531 | 1,421 |
| Commitments and contingencies (Note 11) | 0 | 0 |
| Shareholders equity: | ||
| Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding | 0 | |
| Common stock, par value $0.01: 3,200 shares authorized; 1,691 shares issued and 1,140 shares outstanding at December 31, 2014 and 1,680 shares issued and 1,180 shares outstanding at December 31, 2013 | 17 | 17 |
| Treasury stock, at cost: 550 shares at December 31, 2014 and 500 shares at December 31, 2013 | (24,078) | (20,169) |
| Shares held in trust: 1 share at December 31, 2014 and 2013 | (31) | (31) |
| Capital surplus | 30,418 | 29,777 |
| Retained earnings | 31,849 | 28,493 |
| Accumulated other comprehensive income (loss) | (217) | (149) |
| Stockholders' Equity Attributable to Parent | 37,958 | 37,938 |
| Stockholders' Equity Attributable to Noncontrolling Interest | 5 | 0 |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | 37,963 | 37,938 |
| Total liabilities and shareholders equity | 74,252 | 71,526 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2014 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |